Substance / Medication

Coenzyme Q10

Overview

Active Ingredient
ubidecarenone
RxNorm CUI
21406

Indications

Suggest use: As a dietary supplement, adults take one (1) capsule daily preferably with a meal or as recommended by a physician.

Labeler: Pure Source, LLCUpdated: 2023-11-22T00:00:00.000ZFull label on DailyMed

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

1 trials linked to this intervention

1
Total Trials
0
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis.
Kovacic Svenja, Habicht Sandra D, Eckert Gunter Peter · J Nutr Sci · 2025
PMID: 41158831Meta-AnalysisFull text (PMC)
Clinical efficacy of adjunctive use of coenzyme Q10 in non-surgical periodontal treatment: A systematic review.
Fernandez Matheus Dos Santos, Martins Thiago Marchi, Meza-Mauricio Jonathan et al. · Eur J Oral Sci · 2025
PMID: 39920883Meta-Analysis
The effect of coenzyme Q10 supplementation on depressive symptoms and anxiety: a systematic review and meta-analysis of randomized controlled trials.
Akwan Rami, Elsharkawy Muhammad M, Zrineh Azzam et al. · Eur J Clin Pharmacol · 2025
PMID: 40833470Meta-Analysis
Effects of Coenzyme Q10 Supplementation on Metabolic Indicators in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Li Yinshuang, El-Sehrawy Amr Ali Mohamed Abdelgawwad, Shankar Amar et al. · Clin Ther · 2025
PMID: 39904656Meta-Analysis
Coenzyme Q10 supplementation in multiple sclerosis; A systematic review.
Salekzamani Shabnam, Pakkhesal Sina, Babaei Mohammad et al. · Mult Scler Relat Disord · 2025
PMID: 39667129Meta-Analysis
Combination of trimetazidine and coenzyme Q10 for the treatment of acute viral myocarditis: a systematic review and meta-analysis.
Zeng Min, Chen Zhi, Zhang Yan et al. · J Infect Dev Ctries · 2024
PMID: 38865387Meta-Analysis
Coenzyme Q10 supplementation in rheumatic diseases: A systematic review.
Freire de Carvalho Jozélio, Skare Thelma · Clin Nutr ESPEN · 2024
PMID: 38220408Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ubidecarenone (substance)
SNOMED CT
412129003
UMLS CUI
C0041536
RxNorm CUI
21406
Labeler
Pure Source, LLC

Clinical Data

This intervention maps to 24 entities in the Healos knowledge graph.

7
Conditions
9
Biomarkers
4
Specialists
0
Symptoms
1
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.